CAUTION: Investigational device. Limited by Federal (United States) law to investigational use only.
reSept and atHeart Medical are registered trademarks of atHeart Medical.
© 2021 atHeart Medical. All Rights Reserved
The reSept ASD Occluder has been studied in extensive preclinical studies, with data published in EuroIntervention 2017.
Data from the First-In-Human study were presented at the 2016 Transcatheter Cardiovascular Therapeutics (TCT) Conference.